+91 80 2808 2808
Biocon  /  About Us  /  Who we are  /  Biocon’s Business Model


A strategy of being profitably smart and socially good to provide affordable access to advanced biopharmaceuticals for global patient populations.

A motivation to enter niche areas where we perceive the potential to moderate costs and widen patient access.

 A collaborative model that allows us to share risk and reward of drug development through research partnerships and extend our global footprint through local marketing alliances.

A business philosophy built around the core values of quality, affordability, reliability and innovation.

An unwavering commitment to stringent quality controls in compliance with best-in-class global standards.

A relentless focus on chronic disease spaces like diabetes, cancer and autoimmune / inflammation.

A portfolio approach focused on chronic disease segments and integrating well validated target-to-clinic-to-counter capabilities.

An obligation to develop affordable blockbuster drugs with the potential to benefit a billion patients.

Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>